Ashwagandha root powder and extract are different preparations. A larger milligram number does not tell you which is the better match. Look for the plant part, whether an extract is identified, any declared standardization, and the amount per serving. If you want the preparation used in a particular study, match those details rather than just the word ashwagandha.
Root, powder and extract answer different questions
Root identifies the plant part. Root powder describes ground root material. Root extract describes a preparation made by extracting constituents from root. An extract can be dried, so its powdery appearance does not make it ordinary root powder. NIH explains how botanical extracts are prepared.
That distinction matters when a label is less specific than the article you are reading. A panel that says only root should stay root in your comparison notes. It should not silently become root powder, a branded extract or a guaranteed withanolide amount.
Also keep root and leaf separate. An extract made from both is a different ingredient description from a root-only extract. NIH's ashwagandha review describes research using several plant parts and preparations. There is no single study product called simply ashwagandha.
A completed comparison: DAYLO and NOW
These two products illustrate a less-specific root declaration and a declared standardized extract. They were selected for that contrast, not as the two best products. The table uses official product information checked October 29, 2026; neither finished product was laboratory-tested for this article.
| Field | DAYLO Ashwagandha | NOW Ashwagandha 450 mg Veg Capsules, 30-count |
|---|---|---|
| Plant part | Withania somnifera root | Withania somnifera root and leaf |
| Preparation wording | Label lists organic ashwagandha root; no extract declared | Ashwagandha extract |
| Amount per label serving | 650 mg root per capsule | 450 mg extract per capsule |
| Standardization | No withanolide percentage declared | Minimum 2.4% total withanolides |
| Remaining formula | 5 mg organic black pepper fruit; pullulan capsule | Hypromellose capsule, stearic acid and rice flour |
| Manufacturer's daily schedule | 1 capsule twice daily | 1 capsule 2–3 times daily |
| Package duration at that schedule | 60 capsules: 30 days | 30 capsules: 10–15 days |
Sources: DAYLO's page and Supplement Facts; NOW's current online Supplement Facts and directions. Match the version on the bottle you buy: an older retailer image may show different wording.
DAYLO's label serving is one capsule, while its directions use two over the day. Thus 60 label servings mean 30 days at the stated schedule. NOW's stated frequency produces a range. Keep servings and days in separate fields when comparing package value.
What the percentage lets you calculate
For NOW's declared extract, 450 mg × 0.024 = 10.8 mg. That is the minimum total-withanolide amount implied by the manufacturer's percentage per one-capsule serving. It is label arithmetic, not an independent test result or a recommendation to take that amount.
You cannot repeat the calculation for DAYLO because its panel supplies no percentage. Do not fill the missing field with NOW's percentage, the percentage from a study, or an assumed average for the plant. Undeclared does not mean absent; it means the label does not quantify it.
A percentage also leaves questions open. Which constituents and assay does it cover? Does the declaration apply to this exact extract? Standardization helps describe a preparation but does not turn different extracts into the same ingredient or predict your response. Ask the manufacturer to resolve ambiguous wording rather than treating every percentage as interchangeable.
What is KSM-66 ashwagandha?
KSM-66 is a branded ashwagandha root extract made by Ixoreal Biomed. The 2012 trial below used it, standardized to at least 5% withanolides. DAYLO does not contain KSM-66 or any branded extract; its label lists ashwagandha root.
What one actual trial found, and what it did not
Here is an evidence match you can inspect rather than a general claim that ashwagandha is clinically studied.
Chandrasekhar, Kapoor and Anishetty, 2012
- Preparation: KSM-66 root-only extract, standardized to at least 5% withanolides by HPLC; supplied by Ixoreal Biomed.
- Participants: 64 adults aged 18–54 with elevated stress, excluding psychiatric or chronic systemic illness; 61 were included in the efficacy analysis.
- Design: One-center, randomized, double-blind, placebo-controlled trial lasting 60 days; 300 mg extract twice daily.
- Reported result: Perceived Stress Scale scores fell 44.0% from baseline in the extract group versus 5.5% with placebo; the difference in reductions was statistically significant.
- Limits: Small, short study in a selected population. These changes are questionnaire results, not a promise that a person will feel “44% less stressed.”
This was not a trial of DAYLO, ordinary root powder, or the NOW root-and-leaf extract compared above. The study's named preparation and standardization differ from those declarations. The trial does not provide a conversion factor between them. Its amount and schedule describe the experiment; they do not replace the directions on another product.
The broader evidence deserves the same care. NIH describes studies with different formulations and generally limited follow-up. A study on a particular extract can be relevant to that preparation while leaving unanswered questions about long-term use, other populations and another finished formula. Do not let a familiar botanical name erase those differences.
How much ashwagandha per day?
It depends on the preparation. In the clinical trials summarized by NIH, extracts were used at about 240 to 1,250 mg a day, and one study used whole-root granules at roughly 12,000 mg a day. Those amounts describe specific study products, so they cannot be converted into capsules of another preparation. Follow your product's directions: DAYLO's is one capsule (650 mg root) twice daily. Source: NIH Office of Dietary Supplements.
Check suitability before choosing either preparation
Ashwagandha is not suitable for everyone. NCCIH advises avoiding it during pregnancy and breastfeeding and for hormone-sensitive prostate cancer. It is not recommended for people with thyroid or autoimmune disorders or an upcoming surgery.
Possible effects include drowsiness, stomach upset, diarrhea and vomiting; rare liver injury has been reported. Long-term safety remains uncertain. Potential interactions include thyroid hormone, sedatives, anti-seizure medicines, immunosuppressants, and medicines for diabetes or high blood pressure. Review your conditions, medicines and other supplements with a healthcare professional before use. NCCIH's safety guidance applies regardless of whether a product looks more natural or more concentrated.
Three questions worth settling before checkout
Is root powder the same as root extract?
No. Root powder retains the ground-root preparation; extraction changes how constituents are obtained. If a product says only root, ask for preparation details instead of assigning it to either category yourself.
Does black pepper make DAYLO equivalent to a studied extract?
No such equivalence is established by its ingredient list. DAYLO declares black pepper fruit, not a standardized piperine extract or a measured absorption increase. A familiar additional ingredient cannot supply the missing preparation or standardization match.
Which label should I choose?
If you want a root-only ingredient, DAYLO's label meets that requirement; the NOW extract in this comparison includes leaf, and NIH notes that root and leaf differ in chemical composition. If you require a specified standardized extract, keep that requirement: DAYLO's present declaration does not meet it. If you prefer its particular root-and-black-pepper formula, review DAYLO's complete ingredients and directions, including whether it is appropriate for you. It is also part of DAYLO's Wind-Down routine with magnesium glycinate; see how to read a magnesium glycinate label. If you are choosing because of a study, verify the exact preparation first and discuss the evidence with a qualified healthcare professional. A bigger milligram number should not make that decision for you.
Sources and how this guide was checked
Official DAYLO and NOW declarations were checked October 29, 2026. The worked trial example comes from the original paper; broader evidence and safety context come from NIH ODS and NCCIH. Manufacturer declarations, published research and our arithmetic are identified separately. Current physical inventory and lot-specific potency were not verified.
General information, not personal medical advice.